Dermata Therapeutics Inc. (DRMA)

1.15

0.01 (0.88%)

At close: Mar 03, 2025, 3:59 PM

1.14

-0.87%

After-hours: Mar 03, 2025, 04:17 PM EST

Dermata Therapeutics Cash Flow Statement

Table Mode

Year	FY23	FY22	FY21	FY20	FY19
Net Income	-7.79M	-9.61M	-7.9M	-3.24M	-4.72M
Depreciation & Amortization	n/a	n/a	n/a	322.00	1.35K
Stock-Based Compensation	522.08K	930.33K	1.91M	n/a	730.96
Other Working Capital	494.35K	-135.03K	-121.42K	-522.94K	-197.41K
Other Non-Cash Items	n/a	930.33K	14.13K	-36.49K	872.72K
Deferred Income Tax	n/a	n/a	n/a	n/a	-730.96
Change in Working Capital	863.68K	-153.58K	289.55K	-755.85K	-74.99K
Operating Cash Flow	-6.41M	-8.83M	-5.69M	-4.03M	-3.92M
Capital Expenditures	n/a	n/a	n/a	n/a	n/a
Acquisitions	n/a	n/a	n/a	n/a	n/a
Purchase of Investments	n/a	n/a	n/a	n/a	n/a
Sales Maturities Of Investments	n/a	n/a	n/a	n/a	n/a
Other Investing Acitivies	n/a	n/a	n/a	n/a	n/a
Investing Cash Flow	n/a	n/a	n/a	n/a	n/a
Debt Repayment	n/a	n/a	1.01M	-676.59K	-626.17K
Common Stock Repurchased	-40	n/a	-1M	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	187.00	287.00	-430K	3.24M	5.36M
Financial Cash Flow	7.61M	4.28M	15.96M	2.57M	4.73M
Net Cash Flow	1.2M	-4.56M	10.27M	-1.46M	812.19K
Free Cash Flow	-6.41M	-8.83M	-5.69M	-4.03M	-3.92M